Arthritis & Rheumatism · 1979 · 26 citations · 4 references
MedicinePathobiologyPathologyAutoimmunityMolecular PathologyRheumatologyAutoimmune Rheumatic DiseasesJoint DiseaseJoint DisordersJoint PathologyRheumatoid ArthritisCeramide MetabolismDegenerative Cell ChangesFabry DiseaseInterphalangeal Joint AnatomyInterphalangeal Joint DegenerationSynovial Joint Capsule
Abstract Fabry disease, an X‐linked recessively inherited glycosphingolipidosis, results from defective activity of the lysosomal enzyme ceramide trihexosidase termed α‐galactosidase A (1). The cumulative deposition of the substrate ceramide trihexose (CTH) in various tissues accounts for the clinical manifestations of the disease (2). Although excruciating pains in the extremities are frequently present, pains localized in joints are uncommon. There is a characteristic arthropathy of the distal interphalangeal joints of the fingers with limitation of extension and degenerative changes which are evident on radiologic examination (3). Because patients with Fabry disease have attacks of fever, pains in extremities, and elevated ESR, rheumatic fever or rheumatoid arthritis is frequently the initial diagnosis (3). We wish to report synovial and joint capsule biopsies from a male who was initially diagnosed as having rheumatoid arthritis and was later confirmed to have Fabry disease by low plasma α‐galactosidase level.
4
Enzymatic Defect in Fabry's Disease
Roscoe O. Brady, Andrew E. Gal, Roy M. Bradley et al. · New England Journal of Medicine · 1967 · 1.1K citations
Relief of pain of Fabry's disease by diphenylhydantoin
Lawrence A. Lockman, Donald B. Hunninghake, William Krivit et al. · Neurology · 1973 · 90 citations